Targacept's Diabetic Gastroparesis Drug Fails To Impress

We remind investors that Targacept is set to merge with Catalyst Biosciences, Inc., a privately held biopharmaceutical company. The combined company is expected to take up the name Catalyst Biosciences, Inc.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.